C. Mel Wilcox

1.3k total citations
36 papers, 697 citations indexed

About

C. Mel Wilcox is a scholar working on Surgery, Epidemiology and Oncology. According to data from OpenAlex, C. Mel Wilcox has authored 36 papers receiving a total of 697 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 15 papers in Epidemiology and 9 papers in Oncology. Recurrent topics in C. Mel Wilcox's work include Pneumocystis jirovecii pneumonia detection and treatment (10 papers), Gastrointestinal disorders and treatments (7 papers) and Cytomegalovirus and herpesvirus research (6 papers). C. Mel Wilcox is often cited by papers focused on Pneumocystis jirovecii pneumonia detection and treatment (10 papers), Gastrointestinal disorders and treatments (7 papers) and Cytomegalovirus and herpesvirus research (6 papers). C. Mel Wilcox collaborates with scholars based in United States, Germany and Serbia. C. Mel Wilcox's co-authors include David A. Schwartz, Robert F. Straub, W. Scott Clark, Lorraine N. Alexander, Audrey J. Lazenby, Nuzhat Iqbal, Donna Salzman, Shyam Varadarajulu, Naga Chalasani and Klaus Mönkemüller and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

C. Mel Wilcox

34 papers receiving 680 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Mel Wilcox United States 17 319 295 139 138 102 36 697
Rushikesh Shah United States 12 123 0.4× 245 0.8× 93 0.7× 71 0.5× 96 0.9× 66 591
Milton L. Wagner United States 12 154 0.5× 361 1.2× 198 1.4× 111 0.8× 196 1.9× 36 767
Tomas Vikerfors Sweden 17 333 1.0× 188 0.6× 103 0.7× 118 0.9× 76 0.7× 30 817
Eric Ponette Belgium 15 289 0.9× 596 2.0× 61 0.4× 107 0.8× 256 2.5× 62 1.1k
E. Renoult France 19 218 0.7× 334 1.1× 189 1.4× 104 0.8× 169 1.7× 67 1.1k
Meral Gültekin Türkiye 16 174 0.5× 105 0.4× 88 0.6× 91 0.7× 57 0.6× 63 652
Jonathan Macdonald United Kingdom 13 573 1.8× 201 0.7× 29 0.2× 111 0.8× 33 0.3× 53 939
Charles W. Nordstrom United States 13 169 0.5× 110 0.4× 31 0.2× 119 0.9× 40 0.4× 24 434
Adeline Germain France 22 325 1.0× 751 2.5× 226 1.6× 105 0.8× 175 1.7× 95 1.3k
R. J. A. Diepersloot Netherlands 13 296 0.9× 114 0.4× 35 0.3× 138 1.0× 41 0.4× 16 591

Countries citing papers authored by C. Mel Wilcox

Since Specialization
Citations

This map shows the geographic impact of C. Mel Wilcox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Mel Wilcox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Mel Wilcox more than expected).

Fields of papers citing papers by C. Mel Wilcox

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Mel Wilcox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Mel Wilcox. The network helps show where C. Mel Wilcox may publish in the future.

Co-authorship network of co-authors of C. Mel Wilcox

This figure shows the co-authorship network connecting the top 25 collaborators of C. Mel Wilcox. A scholar is included among the top collaborators of C. Mel Wilcox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Mel Wilcox. C. Mel Wilcox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wilcox, C. Mel, et al.. (2024). Beta-blockers and cirrhosis: Striking the right balance. The American Journal of the Medical Sciences. 367(4). 228–234. 1 indexed citations
3.
Mullarkey, Michael F., et al.. (2020). Factitious Gastrointestinal Bleeding: A Case Series and Review. The American Journal of the Medical Sciences. 362(5). 516–521.
4.
Roberts, Brian S., Andrew A. Hardigan, Marie K. Kirby, et al.. (2015). Blocking of targeted microRNAs from next-generation sequencing libraries. Nucleic Acids Research. 43(21). gkv724–gkv724. 16 indexed citations
5.
Peter, Shajan & C. Mel Wilcox. (2015). Radiofrequency ablation therapy – the grave for GAVE (gastric antral vascular ectasia)?. SHILAP Revista de lepidopterología. 3(2). E128–E129. 8 indexed citations
6.
Mönkemüller, Klaus, et al.. (2014). Utility of double-balloon enteroscopy in patients with left ventricular assist devices and obscure overt gastrointestinal bleeding. Endoscopy. 46(11). 986–991. 11 indexed citations
7.
Mönkemüller, K., Daniel Popa, Jayapal Ramesh, & C. Mel Wilcox. (2013). Two techniques for guide wire advancement along a tortuous pancreatic duct: the through-the-stent and flipped “U-wire” techniques. Endoscopy. 45(S 02). E183–E184. 1 indexed citations
8.
Ladabaum, Uri, Joel V. Brill, Amnon Sonnenberg, et al.. (2012). How to Value Technological Innovation: A Proposal for Determining Relative Clinical Value. Gastroenterology. 144(1). 5–8. 6 indexed citations
9.
Jovanović, Ivan, et al.. (2011). Therapeutic and interventional endoscopy for gastrointestinal bleeding. European Journal of Trauma and Emergency Surgery. 37(4). 339–351. 1 indexed citations
10.
Iqbal, Nuzhat, Donna Salzman, Audrey J. Lazenby, & C. Mel Wilcox. (2000). Diagnosis of gastrointestinal graft-versus-host disease. The American Journal of Gastroenterology. 95(11). 3034–3038. 65 indexed citations
11.
Chalasani, Naga & C. Mel Wilcox. (1999). Gastrointestinal Hemorrhage in Patients with AIDS. AIDS Patient Care and STDs. 13(6). 343–346. 16 indexed citations
12.
Chalasani, Naga, Kiran Patel, W. Scott Clark, & C. Mel Wilcox. (1998). The Prevalence and Significance of Leukocytosis in Upper Gastrointestinal Bleeding. The American Journal of the Medical Sciences. 315(4). 233–236. 20 indexed citations
13.
Chalasani, Naga, et al.. (1997). Barrett's Adenocarcinoma in a Patient With Acquired Immune Deficiency Syndrome. Journal of Clinical Gastroenterology. 24(3). 184–186. 2 indexed citations
14.
Wilcox, C. Mel, et al.. (1996). Symptom-Specific Use of Upper Gastrointestinal Endoscopy in Human Immunodeficiency Virus-Infected Patients Yields High Dividends. Journal of Clinical Gastroenterology. 23(4). 292–298. 17 indexed citations
15.
Schwartz, David A., et al.. (1996). Atovaquone is effective treatment for the symptoms of gastrointestinal microsporidiosis in HIV-1-infected patients. AIDS. 10(6). 619–624. 26 indexed citations
16.
Wilcox, C. Mel, Robert F. Straub, Lorraine N. Alexander, & W. Scott Clark. (1996). Etiology of esophageal disease in human immunodeficiency virus-infected patients who fail antifungal therapy. The American Journal of Medicine. 101(6). 599–604. 16 indexed citations
17.
Wilcox, C. Mel, Robert F. Straub, & David A. Schwartz. (1996). Prospective evaluation of biopsy number for the diagnosis of viral esophagitis in patients with HIV infection and esophageal ulcer. Gastrointestinal Endoscopy. 44(5). 587–593. 29 indexed citations
18.
Wilcox, C. Mel, Robert F. Straub, & W. Scott Clark. (1995). Prospective evaluation of oropharyngeal findings in human immunodeficiency virus-infected patients with esophageal ulceration.. PubMed. 90(11). 1938–41. 40 indexed citations
19.
Wilcox, C. Mel, Robert F. Straub, & David A. Schwartz. (1995). Cytomegalovirus esophagitis in AIDS: A prospective evaluation of clinical response to ganciclovir therapy, relapse rate, and long-term outcome. The American Journal of Medicine. 98(2). 169–176. 33 indexed citations
20.
Wilcox, C. Mel, Robert F. Straub, & David A. Schwartz. (1994). Prospective endoscopic characterization of cytomegalovirus esophagitis in AIDS. Gastrointestinal Endoscopy. 40(4). 481–484. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026